| Abstrakt: |
Inventors from Oxford, UK have filed a patent application for a transdermal vaccine that aims to address the drawbacks of traditional vaccine delivery methods. The application describes the development of biodegradable particles made from polypeptides that can be administered through the skin using ultrasound. These particles have shown promising results in transdermal delivery and can also serve as vaccines or carriers for vaccines. The patent application provides comprehensive information on the composition, particle size, surface indentations, and production methods of this potential breakthrough in transdermal vaccination technology. [Extracted from the article] |
